Event Recap


Join us on June 23rd at 12:00PM ET for part one of Diversity & Clinical Trials, Access & Trust. Our panel of speakers will investigate how recurring challenges in patient access to clinical trials affect study design, recruitment & retention, and diversity in data sets. What efforts should trial stakeholders explore to build trust and encourage buy-in into the trial process amongst diverse communities that are continually underrepresented?

Moderated by:

  • Kimberly Tableman — CEO, Medicine X

Featuring special guests:

  • Ramona Burress — Associate Director, Diversity & Inclusion in Clinical Trials, The Janssen Pharmaceutical Companies of Johnson & Johnson
  • Eric Roberts — Vice President, Trial Diversity & Inclusion, Real Chemistry
  • Sophia Goodison —Director, Oncology, Safety Evaluation and Risk Management (SERM) Scientist, GSK